Cell Cycle Inhibitors in Cancer Therapy: Current Strategies - Rilegato

Perich, Shawn J.; Giordano, Antonio; Soprano, Kenneth J.

Rilegato

ISBN 10: 0896039307 ISBN 13: 9780896039308

Casa editrice: Springer Nature B.V., 2002

Riassunto

Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic diseases.

Su questo libro

Dalla quarta di copertina

The molecular approach to disease continues to yield a tremendous amount of new information about those aspects of cellular replication that we use to understand, prevent, diagnose, and cure cancer. In Cell Cycle Inhibitors in Cancer Therapy: Current Strategies, recognized clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell-cycle control and demonstrate its clinical relevance to understanding neoplastic diseases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor-suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac.
Up-to-date and richly instructive, Cell Cycle Inhibitors in Cancer Therapy: Current Strategies brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease.

Dettagli dell'edizione

• Editore: Springer Nature B.V.
• Data di pubblicazione: 2002
• Lingua: Inglese
• ISBN 10: 0896039307
• ISBN 13: 9780896039308
• Rilegatura: Copertina rigida
• Numero di pagine: 340
• Contatto del produttore: non disponibile
• Persona responsabile: GPSR Kontakt; gpsr@libri.de; ; Europaallee 1; Bad Hersfeld; 36244; Germania